top of page

Our Mission:

To optimize clinical decision making and improve patient safety 

with cost effective, environmentally friendly surgical systems.

About Us

RevMedica is a pioneering MedTech company set to revolutionize the way surgeons approach soft tissue management. 

The RevMedica team is passionate about delivering enabling technology, better clinical results, and a more sustainable operating room environment.

 

We are proud to have the support of highly engaged leading venture investors, driving growth and profitability while staying true to our vision and values.

Meeting Room

Our Team

Our highly experienced team has been a driving force behind innovation in MedTech since the inception of the segment, with 190+ patents worldwide and a track record of successful commercialization for multiple large-cap companies and start-ups.

RevMedica Executive Team

Thomas G Wenchell Co-Founder and CEO of

Chief Executive Officer and Co-Founder

Thomas Wenchell

Tom co-founded RevMedica in 2017, with the vision to revolutionize surgical procedures. With over 30 years of experience in the medical device industry and a wealth of expertise in engineering and product development, Tom has established himself as a global leader in the field. He possesses over 100 issued patents, a testament to his innovative contributions to the industry. Tom's accomplishments speak to his ability to navigate complex challenges and drive innovation in the medical device industry. At RevMedica, Tom leads the development of a novel, handheld robotic solution intended to optimize clinical decision-making and improve patient safety with a cost-effective and environmentally friendly surgical system. Under his leadership, RevMedica has amassed a robust patent portfolio, assembled a team of key advisers, and successfully demonstrated the feasibility of RevMedica’s core design. Tom’s visionary leadership extends beyond product development. He has played a pivotal role in shaping RevMedica's strategic direction, building a talented team, and securing funding to support the company's growth. His hands-on approach to every aspect of the business underscores his dedication to ensuring the success of RevMedica.

  • LinkedIn
Joseph Leveillee Director of Quality RevMedica_edited.png

Director of Quality

Joseph Leveillee

Joe joined the RevMedica executive team in 2023. He has a B.S. in Mechanical Engineering from the University of New Haven and 18 years of Medical Device experience. Joe is an expert in Quality Assurance and has diverse experience from his involvement in all phases of product lifecycle for many disposable and reusable medical devices, both from Covidien (Medtronic) as well as others. Joe always holds patient safety at the center of his focus and has followed the pursuit of improving clinical outcomes throughout his career.

  • LinkedIn
Steve Lampkin Bio Photo_edited.png

Chief Commercial Officer

Steve Lampkin

Steve joined the RevMedica executive team in 2024. He is a seasoned business leader known for his strategic vision and execution capabilities. With a career spanning over two decades, Steve has held key roles in various industries, demonstrating a consistent drive for growth and innovation. Most recently, Steve served as Vice President of Strategy & Corporate Development at Prosidyan, Inc., where he played a pivotal role in a successful exit in 2022. Since then, he has consulted with several companies helping to refine their go to market strategy. His extensive experience also includes leadership positions at United States Surgical Corporation, Johnson & Johnson/DePuy Synthes Spine and Paradigm Spine, LLC, where he consistently exceeded sales targets and drove territory market share growth. His diverse experience delivering above market growth in both small start-ups and large companies makes him an ideal fit for the lead commercial role at RevMedica.

  • LinkedIn
Tim Howe_Executive Chair_RevMedica_edite

Executive Chair

Tim Howe

Tim joined the RevMedica executive team in 2022. He has over 30 years’ experience as a venture capitalist investing in early stage companies in the healthcare industry, including numerous medical device start-ups that have gone on to become publicly traded companies or sold to strategic buyers, including, General Surgical Innovations, Imagyn Medical Technologies, Advanced Surgical, Revivant, Vascular Pathways, Mevion and Avitus. Tim has been investing in private equity since joining the Schroder Ventures US operation in 1984. He went on to form Collinson Howe Venture Partners (“CHVP”) in 1990, which has managed multiple funds under the names CHL Medical Partners, Biotechnology Investment Group LLC, and HealthInvest Equity Partners, L.P. He has served on over 30 private and public corporate boards. Tim currently serves as President of CHVP, director of Medtel.com Inc., and Venture Partner at Connecticut Innovations. Tim is a graduate of Columbia College and the Columbia Graduate School of Business, where he was an Adjunct Assistant Professor for 17 years teaching Venture Capital Management.

  • LinkedIn

Board of Directors

Our Platform

The novel, patent protected RevMedica platform
will deliver holistic value to the operating room.

AdobeStock_240129222_Preview_edited.jpg
Blue Background

Clinical

Clinical Value
Intraoperative intelligence and
optimize surgical decision making

AEnB2Uo5-4HeHUAugcncLS2G8C5GszMBidbo8hKk
Blue Background

Economic

Economic Value
Enhance workflows and

reduce OR waste

Blades of Grass_edited.jpg
Blue Background

Environmental

Environmental Value
Eliminate toxic battery disposal
and wasteful sterilization cycles

11

issued US patents

03

allowed US patents

12

pending US patents

Tidy Desk

RevMedica News

May 21st, 2024

RevMedica announces appointment of Chief Commercial Officer
Company expands IP portfolio with 11th issued US patent.

MIDDLETOWN, CT: RevMedica, a pioneering MedTech company set to revolutionize the way surgeons approach soft tissue management, is pleased to announce the appointment of Steve Lampkin as Chief Commercial Officer. Steve will oversee the US launch of the company’s powered laparoscopic stapler, which will empower more informed intraoperative decision-making, deliver real-time adjustments during firing, and is ergonomically designed to fit all glove sizes. Steve Lampkin is a seasoned business leader known for his strategic vision and execution capabilities. With a career spanning over two decades, Steve has held key roles in various industries, delivering above market growth in both small start-ups and large companies. Most recently, Steve served as Vice President of Strategy & Corporate Development at Prosidyan, Inc., where he played a pivotal role in achieving market-share gains leading to a successful exit to Johnson & Johnson MedTech. His extensive experience includes leadership positions at United States Surgical Corporation, Johnson & Johnson/DePuy Synthes Spine, and Paradigm Spine, LLC, where he consistently exceeded sales targets and drove adoption of new technology. Commenting on his new appointment, Steve said “RevMedica is an exciting organization at the intersection of technology and healthcare. There’s a clear need for the further development of advanced technologies in soft tissue management, and RevMedica is well positioned to provide unique and significant value to our customers. I continue to be impressed with the team and am excited to bring about this new chapter in surgical stapling.” In further news, the company is pleased to announce it has expanded its IP portfolio with its 11th issued US patent. Commenting on this achievement and the appointment, Tom Wenchell, CEO and Co-Founder, said “We are thrilled to welcome a proven MedTech leader to the team, on the heels of our expanded IP portfolio. We now have added commercial horsepower to lead the upcoming launch of our flagship product and drive sustainable growth of our business.” ### For further information, please contact: Katelyn Raymond RevMedica, Inc. Email: katelyn@revmedica.com About RevMedica RevMedica is a pioneering MedTech company set to revolutionize the way surgeons approach soft tissue management. With a mission focused on optimizing clinical decision-making and elevating patient safety, RevMedica aims to achieve these objectives through the development of cost-effective, environmentally friendly surgical systems. The seasoned RevMedica team is passionate about delivering enabling technology, better clinical results and striving for a more sustainable operating room environment. For more information about RevMedica, visit www.revmedica.com

RevMedica Contact Us

We'd love to hear from you.

To learn more about RevMedica and our novel platform,
fill out the contact form and
we will contact you directly.

Contact Us

Thanks for submitting!

RevMedica, Inc.

213 Court Street Suite 702, Middletown, CT 06457

bottom of page